CN Patent

CN121889398A — 氮杂稠环类化合物及其制备方法和用途

Assigned to Suzhou Ark Biopharmaceutical Co Ltd · Expires 2026-04-17 · 0y expired

What this patent protects

本发明涉及一种通式(I)所示的化合物或其立体异构体、溶剂化物、水合物、前药、稳定的同位素衍生物及药学上可接受的盐，所述化合物对磷酸二酯酶(PDEs)，具体的对PDE4具有很高的抑制活性，同时具有优异的药效、体外/体内药代动力学性质和安全性，临床应用前景高。

USPTO Abstract

本发明涉及一种通式(I)所示的化合物或其立体异构体、溶剂化物、水合物、前药、稳定的同位素衍生物及药学上可接受的盐，所述化合物对磷酸二酯酶(PDEs)，具体的对PDE4具有很高的抑制活性，同时具有优异的药效、体外/体内药代动力学性质和安全性，临床应用前景高。

Drugs covered by this patent

Patent Metadata

Patent number
CN121889398A
Jurisdiction
CN
Classification
—
Expires
2026-04-17
Drug substance claim
No
Drug product claim
No
Assignee
Suzhou Ark Biopharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.